Endogenous DNA Damage and Repair Enzymes —A short summary of the scientific achievements of Tomas Lindahl, Nobel Laureate in Chemistry 2015 by Klungland, Arne & Yang, Yun-Gui
Genomics Proteomics Bioinformatics 14 (2016) 122–125HO ST E D  BY
Genomics Proteomics Bioinformatics
www.elsevier.com/locate/gpb
www.sciencedirect.comNEWS AND VIEWSEndogenous DNA Damage and Repair Enzymes* Corresponding authors.
E-mail: arne.klungland@medisin.uio.no (Klungland A), ygyang@
big.ac.cn (Yang YG).
a ORCID: 0000-0001-7274-3661.
b ORCID: 0000-0002-2821-8541.
Peer review under responsibility of Beijing Institute of Genomics,
Chinese Academy of Sciences and Genetics Society of China.
http://dx.doi.org/10.1016/j.gpb.2015.11.001
1672-0229  2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Beijing Institute of Genomics, Chinese Academy of Scie
Genetics Society of China.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).—A short summary of the scientific achievements of Tomas Lindahl, Nobel
Laureate in Chemistry 2015Arne Klungland 1,2,*,a, Yun-Gui Yang 3,*,b1Department of Microbiology, Division of Diagnostics and Intervention, Institute of Clinical Medicine, Oslo University
Hospital, Rikshospitalet, Oslo NO-0027, Norway
2Department of Molecular Medicine, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo,
Oslo NO-0027, Norway
3CAS Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development,
Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, ChinaReceived 23 October 2015; accepted 12 November 2015
Available online 12 December 2015
Handled by Zhao-Qi WangAbstract Tomas Lindahl completed his medical studies at Karolinska Institute in 1970. Yet, his
work has always been dedicated to unraveling fundamental mechanisms of DNA decay and
DNA repair. His research is characterized with groundbreaking discoveries on the instability of
our genome, the identification of novel DNA repair activities, the characterization of DNA repair
pathways, and the association to diseases, throughout his 40 years of scientific career.DNA is the genetic material that transmits all genetic informa-
tion to the offspring and to do this faithfully, DNA was for
long presumed to be absolutely stable. This hypothesis waschallenged by the early study of Lindahl—Rate of depurination
of native DNA [1]. He also identified numerous endogenous
sources of DNA damage [2–4]. The number of DNA damages
in a single human cell exceeds 10,000 every day and must be
counteracted by special DNA repair processes. Tomas Lindahl
summarized crucial knowledge on endogenous DNA damage
and repair in an important review in 1993—Instability and
decay of the primary structure of DNA [5]. This review also
communicated fundamental knowledge on the stability of
DNA to a broad audience.nces and
Klungland A and Yang YG /Base-excision Repair and Beyond 123Base excision repair is the repair pathway that handles most
of the spontaneous lesions to our genome, such as abasic site
(AP site), uracil, and various alkylated- or oxidized-DNA
bases. Tomas Lindahl identified a New class of enzymes acting
on damaged DNA, including uracil [6,7], the DNA glycosy-
lases. He further characterized DNA glycosylases specific for
numerous damaged bases including methylated [8] and
oxidized bases [9]. Furthermore, he described in detail the
single-nucleotide repair patches generated following repair of
uracil [10] and went on to identify all enzymes required
for complete base excision repair on naked DNA and on
nucleosomes [11–14].
An even more sophisticated strategy for DNA repair, the
adaptive response to alkylating agents, was characterized in
a series of ground-breaking studies. First, he identified the
methylated guanine required for the adaptive response [15]
and later identified the intracellular signal [16] and the ada
gene product with two unique functions in the induction of
alkylation resistance [17]. Tomas Lindahl’s group was also
the key to the identification and characterization of the AlkB
family of dioxygenases [18–20]. The AlkB repair mechanism
was later shown to have fundamental importance for histone
demethylation, 5-methylC hydroxylation, and reversible
RNA methylation.
The list of enzymes, including various DNA glycosylases,
alkyltransferases, endo- and exonucleases identified and char-
acterized by Tomas Lindahl’s group for various aspects of
DNA metabolisms is nearly endless. Some examples are early
studies on uracil [21], hypoxanthine [22], processing of DNA 50
terminal ends [23], poly(ADP-ribose) [24], and the DNA
ligases that complete various repair pathways by sealing
nicks in DNA [26,27], as well as more recent studies onFigure 1 Keynote presentation by Tomas Lindahl at the ‘‘Tomas LTrex1-mediated degradation of single-stranded (ssDNA)
[25]. Several mammalian repair enzymes were further charac-
terized by the design of gene-targeted mice [28–31].
It is probably less known that Tomas Lindahl, early in his
scientific life, also did ground-breaking studies on the genome
of the Epstein–Barr virus (EBV). Of major interest was his ini-
tial characterization of the circular EBV genome [32]. This
study was followed up with a series of important publications
of the EBV DNA in cancer cell lines (e.g., [33]) and also
included the identification of sequence variants of the
Epstein–Barr genome [34].
Tomas Lindahl started his scientific career at Karolinska
Institute, where he completed his PhD in 1967. He did his
postdoctoral training at the Princeton University and the
Rockefeller University and then became a professor at the
University of Gothenburg in 1978. He is world-wide renowned
also for directing the Clare Hall laboratories, part of Cancer
Research UK that became a wonderful place to work and a
leading center for studies on DNA repair and related
processes.
On a more personal note; one, out of many, remarkable
experiences working as postdocs in Tomas Lindahl’s
group at Clare Hall, was his daily walks through his laboratory
asking everybody ‘‘how is it going”, which could lead to a
short answer or a one-hour scientific discussion. This
guidance has continued for years after completing our
postdoctoral training at Clare Hall, for which we are truly
grateful.
Tomas Lindahl gave a keynote presentation at the ‘‘Tomas
Lindahl Conference on DNA Repair” (Figure 1), organized
by his two former postdocs Drs. Yun-Gui Yang and
Arne Klungland in Oslo on June 20, 2015 (Figure 2).indahl Conference on DNA Repair’’, Holmenkollen, Oslo, 2015
Figure 2 Yun-Gui Yang (left) and Arne Klungland (right) with Tomas Lindahl at the ‘‘Tomas Lindahl Conference on DNA Repair’’,
Holmenkollen, Oslo, 2015
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